What it is
Osteoarthritis is progressive wear of joint cartilage. Regenerative medicine doesn't replace the joint — it works on the tissue's residual biological capacity through paracrine signaling. The profile most likely to respond is grade I-III osteoarthritis, evaluated case by case.
✓
Documented cell source — Wharton's jelly (umbilical cord)
✓
Cultured in hypoxia, not normoxia — more potent secretome
✓
GMP traceability and Certificate of Analysis (CoA) per batch
✓
ISCT/ISEV characterization — the same international criteria
Does this sound like you?
✓
Joint pain that appears or worsens with movement
✓
Stiffness that improves briefly with movement, then returns
✓
You were diagnosed with osteoarthritis and don't know what options exist besides anti-inflammatories
✓
You want to slow progression, not just manage the symptom
Today there are more than 1,000 registered clinical trials on regenerative medicine in joint conditions. Your Comprehensive Joint Assessment reviews whether your specific case can benefit — with evidence, not promises.
Current offer
10% off your regenerative treatment
Code: REGEN10
Activates the day of your Comprehensive Joint Assessment and stays valid for 72 hours so you can define your plan with your specialist.
Treatment under individualized medical evaluation, within the applicable regulatory framework.